Showing results (1151-1160 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|September 5, 1995
Theoretical changes in neonatal hospitalisation costs after the introduction of porcine-derived lung surfactant ('Curosurf')J EgbertsPharmacoeconomics|November 7, 2000
Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United KingdomH Freeman, S Arikian, A Lenox-SmithPharmacoeconomics|November 7, 2000
Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgeryD Coyle, K M Lee, D A Fergusson, et al.Pharmacoeconomics|November 7, 2000
Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspectiveS C Wood, V H Nguyen, C SchmidtPharmacoeconomics|November 7, 2000
Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylateJ P Marissal, B Selke, T LebrunPharmacoeconomics|January 11, 2001
Payment systems and considerations of case mix--are diagnosis-related groups applicable in Japan?K KawabuchiPharmacoeconomics|January 11, 2001
HIV-1 drug resistance genotyping. A review of clinical and economic issuesC Chaix-Couturier, C Holtzer, K A Phillips, et al.Pharmacoeconomics|November 1, 2017
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology AppraisalNasuh C Büyükkaramikli, Saskia de Groot, Debra Fayter, et al.Pharmacoeconomics|October 19, 2017
Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC StudyYasuhiro Hagiwara, Takeru Shiroiwa, Kojiro Shimozuma, et al.Pageof 336